A detailed history of Ascent Group, LLC transactions in Danaher Corp stock. As of the latest transaction made, Ascent Group, LLC holds 2,205 shares of DHR stock, worth $596,518. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,205
Previous 1,693 30.24%
Holding current value
$596,518
Previous $422,000 30.33%
% of portfolio
0.05%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $120,581 - $137,205
512 Added 30.24%
2,205 $550,000
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $27,623 - $31,511
123 Added 7.83%
1,693 $422,000
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $22,212 - $27,975
120 Added 8.28%
1,570 $363,000
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $2.88 Million - $3.29 Million
-12,375 Reduced 89.51%
1,450 $359,000
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $161,992 - $184,420
-720 Reduced 4.95%
13,825 $3.32 Million
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $49,628 - $57,339
207 Added 1.44%
14,545 $3.67 Million
Q4 2022

Feb 16, 2023

BUY
$241.42 - $282.29 $74,598 - $87,227
309 Added 2.2%
14,338 $3.81 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $560,332 - $3.42 Million
2,268 Added 19.28%
14,029 $3.53 Million
Q2 2022

Aug 05, 2022

BUY
$237.11 - $299.66 $165,977 - $209,762
700 Added 6.33%
11,761 $3.43 Million
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $116,028 - $142,407
-451 Reduced 3.92%
11,061 $3.25 Million
Q4 2021

Mar 01, 2022

BUY
$292.08 - $329.01 $3.36 Million - $3.79 Million
11,512 New
11,512 $3.23 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.